×
  • Category
  • Type
  • Advanced

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 06: Process of COVID-19 Vaccination Planning, Costing and Budgeting in African Region

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 05: Where does needed COVID-19 Vaccination Funding come from?

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Sessions #02 and #03: COVID-19 Vaccination: Costing for Scale-up

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session #01: How to apply for Gavi CDS Funding through the Partners Platform

Are rotavirus vaccines a good investment for middle-income countries?

Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness

Q&A for Session #13: Private Sector Engagement

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

COVID-19 Vaccine Introduction and deployment Costing tool (‎‎‎‎CVIC tool)

Q&A for Session #11: Mobilizing financing resources for scale up of COVID-19 vaccination

To optimize COVID-19 vaccine rollout, listen to health workers

Tanzania HPV Vaccine Roll Out Plan

KN2.2 Innovating from Research to Impact at Scale: the role of the Gavi Alliance

Global Market Study: Typhoid vaccines - 2020

Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - 2020

Global Market Study: Human Rabies vaccines - 2020

Global Market Study: HPV - 2020

Global Market Study: Measles-containing vaccines (MCV) - 2020

MI4A Vaccine Purchase Data for Countries - 2020

Global Vaccine Market Report - 2020